MIRLET7C: A Potential Drug Target and Biomarker (G406885)

Target Name: MIRLET7C

NCBI ID: G406885

MIRLET7C

MIRLET7C: A Potential Drug Target and Biomarker

MIRLET7C (M7-1) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the Mirlet family of proteins, which are characterized by their ability to form inclusion complexes with a wide variety of small molecules. One of the unique features of MIRLET7C is its ability to form inclusion complexes with small molecules such as drug-like compounds, making it a potential drug target.

The discovery and characterization of MIRLET7C was made by a research team led by Dr. Jian Zhang at the University of California, San Diego. The team used a variety of techniques, including biochemical, cellular, and mass spectrometry, to study the protein and its functions.

MIRLET7C is a member of the Mirlet family of proteins, which are characterized by their ability to form inclusion complexes with a wide variety of small molecules. The Mirlet family includes proteins that are involved in a variety of cellular processes, including cell signaling, DNA replication, and metabolism. MIRLET7C is specifically characterized by its ability to form inclusion complexes with small molecules such as drug-like compounds.

One of the unique features of MIRLET7C is its ability to form inclusion complexes with small molecules such as drug-like compounds. This ability makes MIRLET7C a potential drug target. drug-like compounds, such as small molecules that mimic the structure and function of drugs, can interact with MIRLET7C and disrupt its function, potentially leading to the development of drug resistance.

MIRLET7C is also characterized by its ability to form inclusion complexes with a wide variety of small molecules. This makes it a potential biomarker for a variety of diseases, including neurodegenerative disorders, cardiovascular disease, and diabetes.

MIRLET7C is also involved in a variety of cellular processes that are important for the development and maintenance of tissues and organs. For example, MIRLET7C is involved in the formation of the blood-brain barrier, which is a barrier that separates the brain from the surrounding blood vessels and is important for the delivery of drugs and other therapeutic compounds to the brain. MIRLET7C is also involved in the regulation of cell signaling pathways, which are important for the development and maintenance of tissues and organs.

In conclusion, MIRLET7C is a protein that is characterized by its ability to form inclusion complexes with small molecules such as drug-like compounds. Its unique properties make MIRLET7C a potential drug target and a potential biomarker for a variety of diseases. Further research is needed to fully understand the functions and potential applications of MIRLET7C.

Protein Name: MicroRNA Let-7c

The "MIRLET7C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIRLET7C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets